Document is current
Any future updates will be listed below
-
Authors
Iriarte-Yoller, Nagore
Etxaniz-Oses, José
Pavón-Navajas, Cristobal
Tous-Espelosin, Mikel
Sánchez-Gómez, Pedro M.
Maldonado-Martín, Sara
Yoller-Elburgo, Ana B.
Elizagarate-Zabala, Edorta
- License Information
-
More Information
Article History
Received: 24 August 2024
Accepted: 6 December 2024
First Online: 18 December 2024
Declarations
:
: The design of the study conforms to the principles outlined in the Declaration of Helsinki, and the protocol, together with the informed consent procedures of the TRACE-RMD study, were approved by the Ethics Committee of Investigation of the local Hospital (11 May 2023, Certificate No. 2023–008). The protocol was registered with the United States National Library of Medicine (ClinicalTrials.gov ID no. NCT05136027). Participants will be fully informed of the aims and procedures of the research before collecting their informed consent and before the clinical and physiological examination. Each participant will be allowed to ask questions about the investigation. No identifying images or other personal or clinical details of participants will be presented in reports of the trial results. The participant information materials and informed consent forms are available from the corresponding author on request.
: Not applicable.
: The authors declare that they have no competing interests.
